14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $27.14 $33.02 Wednesday, 24th Apr 2024 AGIO stock ended at $31.67. This is 0.440% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 3.00% from a day low at $31.32 to a day high of $32.26.
90 days $21.66 $35.48
52 weeks $19.80 $35.48

Historical Agios Pharmaceuticals prices

Date Open High Low Close Volume
Mar 19, 2024 $29.35 $30.39 $29.28 $30.09 544 618
Mar 18, 2024 $29.88 $30.00 $28.94 $29.29 520 489
Mar 15, 2024 $29.40 $30.33 $29.40 $29.94 1 186 888
Mar 14, 2024 $29.82 $30.00 $29.02 $29.46 539 440
Mar 13, 2024 $30.31 $30.96 $29.83 $30.00 517 270
Mar 12, 2024 $30.74 $30.87 $30.02 $30.29 517 928
Mar 11, 2024 $31.44 $31.77 $30.68 $30.80 407 572
Mar 08, 2024 $31.81 $32.04 $30.91 $31.29 351 770
Mar 07, 2024 $31.99 $32.60 $31.27 $31.37 580 934
Mar 06, 2024 $31.40 $32.08 $31.14 $31.79 1 605 847
Mar 05, 2024 $31.96 $32.26 $31.25 $31.37 458 882
Mar 04, 2024 $32.43 $32.57 $31.28 $32.17 685 495
Mar 01, 2024 $32.35 $33.04 $32.09 $32.27 841 651
Feb 29, 2024 $34.25 $34.25 $32.24 $32.32 839 751
Feb 28, 2024 $34.55 $35.48 $33.48 $33.67 868 117
Feb 27, 2024 $33.00 $35.48 $32.90 $34.81 1 387 680
Feb 26, 2024 $32.86 $33.69 $32.23 $32.87 941 513
Feb 23, 2024 $29.87 $33.90 $29.87 $32.99 2 567 558
Feb 22, 2024 $26.73 $30.05 $26.66 $29.78 1 504 353
Feb 21, 2024 $27.11 $27.37 $26.50 $26.80 634 728
Feb 20, 2024 $26.19 $27.13 $26.19 $27.10 905 399
Feb 16, 2024 $26.41 $26.91 $26.02 $26.51 620 223
Feb 15, 2024 $24.93 $27.00 $24.88 $26.80 1 081 432
Feb 14, 2024 $25.44 $26.22 $25.20 $25.90 922 356
Feb 13, 2024 $25.12 $25.42 $24.69 $25.15 1 207 611
Click to get the best stock tips daily for free!

About Agios Pharmaceuticals

Agios Pharmaceuticals Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Ph... AGIO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT